Cargando…
Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a systematic review
PURPOSE: We aimed to investigate the role of anti-vascular endothelial growth factor (VEGF) agents, including tyrosine-kinase inhibitors or monoclonal anti-bodies, in the treatment of elderly hepatocellular carcinoma (HCC) patients. MATERIALS AND METHODS: Databases from PubMed, Web of Science and ab...
Autores principales: | Li, Xiaofei, Zhang, Daofu, Guan, Shan, Ye, Weiwei, Liu, Liwen, Lou, Lianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696253/ https://www.ncbi.nlm.nih.gov/pubmed/29190987 http://dx.doi.org/10.18632/oncotarget.21452 |
Ejemplares similares
-
Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis
por: Cao, Guangchao, et al.
Publicado: (2015) -
Dose age affect the efficacy of molecular targeted agents in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis
por: Du, Jing, et al.
Publicado: (2017) -
Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis
por: Hou, Qi, et al.
Publicado: (2017) -
Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017) -
Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis
por: Shang, Jin, et al.
Publicado: (2017)